Arca
Skip to content

Rezum System

Unit, Electrosurgical, Endoscopic (With Or Without Accessories). 510(k) K250584, from Boston Scientific Corporation (Marlboro, MA). Product code KNS, class 2.

As of Nov 17, 2026, K250584 is an FDA 510(k) held by Boston Scientific Corporation, substantially equivalent on Jun 11, 2025 after 104 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 11, 2025
  • Review time: 104 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Rezūm System is intended to relieve symptoms, obstructions, and reduce prostate tissue associated with benign prostatic hyperplasia(BPH). It is indicated for men ≥ 50 years of age with a prostate volume 30 cm3 ≤ 150 cm3. The Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • Rezum SystemK191505 · Nxthera (A Boston Scientific Company) · Aug 2, 2019

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Other KNS Clearances

The newest 510(k)s for the same product code; their median review was 118 days; see every KNS device

Record

Type
Traditional
Received
Feb 27, 2025
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.4300

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.